Iowa pausing Johnson & Johnson vaccine administration

National News

FILE — In this March 31, 2021 file photo, a nurse fills a syringe with a dose of the Johnson & Johnson’s one-dose COVID-19 vaccine at the Vaxmobile, at the Uniondale Hempstead Senior Center, in Uniondale, N.Y. The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. (AP Photo/Mary Altaffer, File)

DES MOINES, Iowa (KCAU) – The Iowa Department of Public Health (IDPH) said it has advised all Iowa vaccine providers to pause the administration of the Johnson & Johnson COVID-19 vaccine.

This comes after the CDC and FDA recommended a pause of the vaccine early Tuesday. In a joint statement, the two agencies said there are six reported cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. 

The CDC and FDA are reviewing data involving six cases in the U.S. Right now, these adverse events appear to be extremely rare with more than 6.8 million doses of the Johnson & Johnson vaccine having been administered as of April 12.

The CDC and FDA is providing a briefing on the recommendation Tuesday morning.

The IDPH said they will provide an update later when they have more details. 

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.